Shalin J. Shah is a Professor at The University of Texas MD Anderson Cancer Center. His research focuses on radiation oncology, with specific interests in proton therapy, MR-guided radiotherapy, and AI-powered treatment planning for resource-limited settings. He has led landmark clinical trials, including a multicentre phase 3 trial comparing proton versus photon radiotherapy for oropharyngeal cancer, published in The Lancet. His recent work also addresses quantitative Dixon-based PDFF and R2* estimation on MR-Linac devices, minority participation in radiation oncology clinical trials, and the safety of contemporary radiation therapy in patients with cardiac implantable electronic devices. He collaborates internationally on AI-driven solutions for cervical and prostate cancer treatment planning.
See moreHonors

Experiences

Education
